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SYNOPSIS

           The thesis entitled “Studies directed towards total synthesis of Spongistatin 1 and other related molecules” has been divided into four chapters.

Chapter-I: This chapter deals with an introduction to cancer and the approaches cited in the literature towards the synthesis of spongistatin 1, including the total synthesis.
Chapter-II: This chapter deals with the chiron approach to spongistatin 1, and is further divided into two sections.
Section-A: Spongistatin synthetic studies: Towards the synthesis of C2-C16 AB fragment of the spongistatin 1.
Section-B: Spongistatin synthetic studies: Towards the synthesis of C17-C28 CD fragment of the spongistatin 1.
Chapter-III: This chapter deals with an introduction to lipoprotein disorders, previous approaches to atorvastatin and stereoselective synthesis of atorvastatin lactone moiety
Chapter-IV: This chapter deals with an introduction to pheromones, the approaches cited   in the literature and “A chiron approach to (1S, 1’R, 5’R, 7’R)-1 and (1S, 2R, 5R, 7S)-2-hydroxy-exo-brevicomins” 

CHAPTER-I: An introduction to cancer and the approaches cited in the literature towards the synthesis of spongistatin 1, including the total synthesis.

 CHAPTER-II:  
 Section-A: Spongistatin synthetic studies: Towards the synthesis of C2-C16 AB fragment   of the spongistatin 1.

           The spongipyran marine macrolides were reported independently by three research groups in 1993. Pettit and coworkers extracts spongistatins from spongia species and spirastrella spinispirulifera, Kitagawa/kobayashi group reported altohyrtins A-C and 5 desaacetyl altohyrtin A from hyrtios altum and Fusetani reported the isolation of  cinachyrolide A from cinachyra sponges (Figure 1).
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            The spongistatins (altohyrtins) have been found to be extraordinarily effective against a variety of chemoresistant tumor types, which comprise the NCI panel of 60 human cancer cell lines. Human melanoma, lung, brain, and colon cancers were found to be especially sensitive to spongistatin-1 (1a). The impressive biological activity and the unique structure of spongistatins led to efforts directed toward the synthesis of these compounds. The first total synthesis of spongistatin 1 was reported in 1997 by Kishi and coworkers and subsequently reported by some other groups.
                                                                               
        
                                              
                      Our strategy for the total synthesis of this captivating marine natural product (spongistatin 1) involves its disconnection across the lactone linkage (C1-O) and the cis alkene (C28-C29) to generate the upper, C1-C28 ABCD segment 2, together with an appropriate lower segment 3 containing the E and F rings. The fragment 2 was further disconnected into the C(1-2) which gives C2-C28 ABCD fragment 4 and it was further disconnected C(16-17) bond which led to the key building blocks 5 and 6 respectively. In continuation of our program on the total synthesis of spongistatin 1, herein we describe the synthesis C2-C16 AB fragment 5 involving the chiron approach using D- sorbitol 9, L-ascorbic acid 22 and (S)-2-methyl-3-hydroxy propionate 35 (Roche ester) as starting materials (SCHEME-1). 
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Synthesis of C2-C6 AB spiroketal subunit:    
           The readily available D-sorbitol 9 was transformed into 1,3:2,4:5,6-tri-O-methylene-D-sorbitol 10 in 68% yield by a well documented procedure. Selective cleavage of the 1,3 and 5,6-O-methylene bridge occurred when compound 10 was treated with a mixture of acetic acid, acetic anhydride and catalytic con. H2SO4 to give the tetra acetate 11 and subsequent Zemplen deacetalisation of 11 using catalytic sodium methoxide in chloroform afforded the tetrol 12 in quantitative yield. The tetrol 12 was then converted to the 1,3;5,6-di-O-isopropylidene derivative 13 on treatment with 2, 2-dimethoxy propane in presence of catalytic p-TSA in dry acetonitrile in 65% yield. Selective deketalisation of the six membered 1, 3-O-isopropylidene ring was achieved in compound 13 by using catalytic p-TSA in methanol for 2 h to provide the 1,3-diol 14 (SCHEME-2). 



           Regioselective protection of the primary hydroxyl group of the diol 14, with bis(dibutyl)tinoxide (stannyl ester activation) and subsequent benzylation  with BnBr provided the desired benzyl ether 15 (Regioselectivty > 9:1) in 87% yield. The secondary hydroxyl group of benzyl ether 15 was deoxygenated in a two step sequence. First, 
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 compound 15 was transformed into its corresponding xanthate 16 by treating with sodium hydride (60% w/v dispersion oil), carbon disulfide and methyl iodide in dry THF at 0 0C in 95% yield. The xanthate 16 was subjected to Barton- McCombie protocol under standard conditions using tri-n-butyltin hydride and catalytic amount of AIBN as radical initiator in refluxing toluene to afford the deoxy benzyl ether 17 in good yield (93%). Deprotection of acetonide group of compound 17 was achieved by using catalytic amount of p-TSA in methanol to afford the diol 18 in 92% yield (SCHEME-3).


           Oxidative cleavage of the diol 18 was achieved with sodium periodate in presence of aqueous saturated NaHCO3 in DCM to furnish the aldehyde 19 in 95% yield. The crude aldehyde 19 was reduced to corresponding alcohol 20 using NaBH4 in dry methanol with 90% yield. Alcohol 20 was treated with triphenyl phosphine, iodine and imidazole in dry DCM at room temperature to afford the crucial intermediate 21 in 75% yield (SCHEME-4). 
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Synthesis of C8-C12 AB spiroketal subunit: 
           The second key intermediate 34 (C8-C12 fragment) for the construction of AB-spiroketal fragment 5 has been synthesized using L-(-)-ascorbic acid as a chiral pool starting material. Accordingly, multi-gram preparation of α-hydroxy-ester 25 started with readily available L-(-)-ascorbic acid 22, which was protected as its acetonide 23 by a well documented procedure. Oxidation of compound 23 with 35% hydrogen peroxide in presence of sodium hydrogen carbonate and 30% aqueous sodium hydroxide in distilled water produced threonic acid sodium salt 24, which was then transformed to α- hydroxyl methyl ester 25 with dimethyl sulphate and sodium hydrogen carbonate at 40 0C in water  in 83% overall yield for two steps. The α-hydroxy ester 25 was treated with methane sulfonyl chloride and pyridine in dichloromethane providing the crystalline mesylate 26 in 95% yield. When mesylate 26 was heated at 85 0C with lithium chloride in dry dimethyl formamide furnished a mixture of the erythro and threo chloro esters 27, 27a in 71% yield (SCHEME-5). 

                8	                     Synopsis


           
           Hydrogenolysis of the diastereomeric mixture of 27, 27a with catalytic 10% Pd/C in presence of triethylamine in methanol afforded the ester 28 in 92%. Treatment of the ester 28 with a three folds excess of methyl magnesium iodide in anhydrous ether to afford the tertiary alcohol 29 in 95% yield.  Dehydration of tertiary alcohol 29 with triethyl amine, methane sulfonyl chloride, catalytic DMAP in dry DCM at -10 0C for 1 h gives inseperable mixture of olefins 30, 30a in 9:1 ratio in 92% yield. The isomeric mixture of olefins 30, 30a was subjected to Sharpless asymmetric dihydroxylation reaction using AD-Mix-α as a chiral catalyst in H2O-ButOH (1:1) at perfectly 0 0C afford the diol 31 (major) along with its isomers (selectivity  > 95 : 5) in 94% yield (SCHEME-6).
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           After chromatographic separation, the synthesis was continued with the major diasteromer 31 whose 1,2-diol functionality was protected as benzylidene acetal using  benzylidene dimethyl acetal and catalytic amount of p-TSA in dry DCM at room temperature, which gives fully protected acetal 32 in 90% yield. Next we selectively opened the benzylidene acetal moiety of compound 32 with DIBAL-H in dry toluene at the less hindered position to liberate the primary alcohol 33 (Major) along with its regio-isomer (regioselectivity > 9.6:0.4) in 92% yield. The primary hydroxyl group of compound 33 was converted to corresponding iodide 34 using iodine, triphenyl phosphine and imidazole in DCM at room temperature in 75% yield (SCHEME-7).  


Synthesis of C13-C16 subunit:
            The reaction sequence started with the formation of α-chiral silyl-protected ester 36 from the commercially available methyl (S)-2-methyl-3-hydroxy propionate 35 (Roche ester) by a known procedure. The ester functionality of silyl-ether 36 was reduced to the corresponding alcohol 37 with sodium borohydride, BF3.Et2O in anhydrous THF at 0 0C in quantitative yield. The alcohol 37 was oxidized to corresponding aldehyde 38 using dry DMSO, oxalyl chloride in dry DCM at -78 0C in 87% yield. The crude aldehyde 38 was subjected to one carbon homologation under the standard conditions using methyl triphenyl phosphorane, n-BuLi in dry THF to afford the olefin 39 in 76% yield (SCHEME-8). 
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           The olefin 39 was treated with Bromine in chloroform at -50 0C to afford the 1,2-dibromo derivative 40 in 98% yield. Exposure of crude dibromo compound 40 to DBU in dry DMF at 60 0C smoothly effected the elimination to give the desired alkyne 41 in 98% yield. Hydrolysis of the primary silyl ether moiety of the alkyne 41 with tetrabutyl ammonium fluoride (TBAF) in dry THF afforded the alkynol 42 in 90% yield. The alkynol 42 was subjected to Swern oxidation using dry DMSO, oxalyl chloride in dry DCM at -78 0C to afford the alkynal 43 in 85% yield. The crude alkynal 43 was subjected to Grignard reaction using ethyl magnesium bromide in dry Et2O to afford a inseperable diastereomeric mixture of alkynol 8 in 91% yield (SCHEME-9).
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           In conclusion, we have developed an efficient route to synthesize the three key intermediates (21, 34 and 8) corresponding to C2-C16 AB spiroacetal subunit of spongistatin 1 starting from inexpensive and commercially available carbohydrate precursors D-sorbitol, L-ascorbicacid and (S)-2-methyl-3-hydroxy propionate in highly efficient fashion. The present method would be utilized as a practical and economical procedure for large scale synthesis of C2-C16 AB spiroacetal subunit, which is useful for the total synthesis of spongistatin 1. 

Section-B: Spongistatin synthetic studies: Towards the synthesis of C17-C28 CD fragment of the spongistatin 1.

           In this section we described our approach to synthesize the C17-C28 CD spiroketal fragment of spongistatin 1 starting from commercially readily available carbohydrate precursors maltodextrin and D-sorbitol. Our retrosynthetic analysis revealed the C17-C28 CD spiroketal fragment 1 could be obtained by spiroketalization of fragment 3 via fragment 2, which was synthesized starting from chiral intermediates iodo compound 4 and epoxide 5 using tosyl methyl isocyanide (TosMIC). Compound 4 was synthesized using D-sorbitol as replenishable starting material as mentioned in section-A. An efficient and practical synthesis of the chiral epoxide 5, started with maltodextrin 6 via boron mediated anti-selective reduction as the key step (SCHEME-10).
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Synthesis of C17-C22 CD subunit:    
           To begin the synthesis, we began with S-(-)-3-hydroxy-γ-butyrolactone 7 derived from oxidation of maltodextrin 6 by a well documented protocol. The lactone moiety of compound 7 was opened with catalytic p-TSA in dry methanol, which gives diol-ester 8 in 89% yield. The diol functionality of the diol-ester 8 was protected as its acetonide 9 using 2, 2-dimethoxy propane and catalytic p-TSA in dry DCM with 96% yield. The ester                               functionality of compound 9 was transformed to corresponding acid 10 using lithium hydroxide in dry THF with 94% yield. The crude acid 10 was converted to corresponding Weinrebamide 11 using N,O-dimethylhydroxylamine hydrochloride, carbonyl diimidazole (CDI) and catalytic DMAP in dry THF in 70% yield (SCHEME-11). 
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           Treatment of the amide 11 with allyl magnesium bromide in dry THF at -78 0C furnished the β,γ-unsaturated ketone 12 in 98% yield. Stereoselective reduction of ketone 12 with tetramethyl ammonium triacetoxy borohydride in presence of AcOH in acetonitrile at -40 0C afforded the anti-alcohol 13 as a major diastereomer, which was masked as the PMB ether 14 using NaH (60% dispersion oil), PMBBr in DMF with 96% yield (SCHEME-12). 
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           Acidic hydrolysis of the PMB-masked ether 14 using catalytic p-TSA in methanol at room temperature provided diol 15 in a highly efficient fashion (94%). Treatment of diol 15 with TsCl and triethylamine in presence of catalytic dibutyltin oxide (Bu2SnO) in dry DCM to give primary tosylate 16 in 89% yield. Finally primary tosylate 16 was converted to corresponding terminal epoxide 5 by treating with potassium carbonate in dry methanol with 90% yield (SCHEME-13). 


           In conclusion, a novel, convenient and practical method has been developed for the synthesis of stereochemically well defined C17 –C28 CD ring intermediates (C17-C22    epoxide 5, C24-C28 iodo compound 4) related to spongistatin 1 using maltodextrin and D-sorbitol as chiral pool starting materials.

Chapter-III: Stereoselective synthesis of atorvastatin lactone moiety.

             In the search for highly potent agents for the treatment of lipoprotein disorders, scientists at Parke-Davis pharmaceutical research division, Warner-Lambert Company (michigan) synthesized CI-981 (atorvastatin 1) as the optimum form for development as hyper cholesterolemic agent. Atorvastatin 1, a highly potent (with five times higher than the fungal metabolite (+)-compactin) and tissue selective inhibitor of HMG-CoA reductase was proven to be an important medicine for the treatment of lipoprotein disorders (Figure 1).
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           Accordingly, our retrosynthetic analysis revealed disconnections of the atorvastatin 1, which led to the key chiral lactone moieties (3A, 3B). In continuation of our research program we report the stereoselective synthesis of atorvastatin lactone moiety in two different models (3A, 3B) using D-glucose 4 as a replenishable starting material. The strategy for constructing the lactone moieties (3A, 3B) is retrosynthetically outlined (SCHEME-1).          
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           1,2-5,6-Di-O-isopropylidene-α-D-glucofuranose 5 was prepared from commercially available D-glucose 4 by a well documented procedure. Diacetone-D-glucose (DAG) 5 was converted into its corresponding xanthate 6 by treating with sodium hydride (60% w/v dispersion oil), carbondisulphide and methyl iodide in dry THF at 0 0C in 91% yield. xanthate 6 was then deoxygenated under Barton-McCombie protocol using tri-n-butyltin hydride and catalytic azobisisobutyronitrile (AIBN) as radical initiator in dry toluene at reflux temperature to afford the 3-deoxy glucose diacetonide 7 in 85% yield. Regioselective mono hydrolysis of 5,6-O-isopropylidene group of 3-deoxy glucose diacetonide 7 with 60% aqueous acetic acid afforded the diol 8 in 85% yield (SCHEME-2).
 


            The diol 8 was transformed to aldehyde 9 under standard conditions using sodium periodate and aqueous saturated sodium hydrogen carbonate in dichloromethane in 96% yield. The crude aldehyde 9 was reduced to corresponding alcohol 10 using sodium borohydride in dry methanol with 90% yield. The primary hydroxyl group of compound 10 was protected as its benzyl ether 11 using sodiumhydride (60% w/v dispersion oil) and benzyl bromide in anhydrous THF in 95% yield. The benzyl ether 11 was converted into its 
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corresponding lactol 12 by treating with 50% aqueous acetic acid and catalytic con. sulphuricacid at 50 0C. The crude lactol 12 was further subjected to one carbon homologation via a Wittig olefination protocol using methyl triphenyl phosphorane and n-butyl lithium in anhydrous THF to yield the desired ene-diol 13 in 76% overall yield for two steps (SCHEME-3). 


           The ene-diol 13 was protected under standard conditions using 2,2-dimethoxy propane and catalytic BF3.Et2O in anhydrous dichloromethane to afford fully protected-ene derivative 14 in 88% yield. Compound 14 was subjected to hydroboration using 9-BBN in anhydrous THF at reflux temperature followed by quenching the boron complex using 2N NaOH and H2O2 to afford the primary alcohol 15 in 93% yield. The primary hydroxyl group of compound 15 was oxidized to corresponding aldehyde 16 using Collins reagent (CrO3.2Py) in anhydrous dichloromethane. The crude aldehyde 16 was further oxidized to acid 17 by treating with pyridenium dichromate (PDC) in anhydrous DMF followed by subjected to lactonization protocol under conditions using few drops of con.HCl in dichloromethane to afford the pure lactone 3A (SCHEME-4). 
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             Having successfully studied the formation of chiral lactone 3A using D-glucose, we then proceeded to apply the similar strategy to construct the lactone 3B from the same starting material (D-glucose).
           The known aldehyde 9 was converted to E, Z-isomeric mixture of olefins 18, 18a under conditions using benzyl triphenyl phosphorane, n-butyl lithium (1.6 M in hexane) in dry THF under Wittig olefination protocol in 75% yield. The isomeric mixture 18, 18a was subjected to hydrogenation by using Pd/C 10% under hydrogen atmosphere in EtoAc gave the saturated compound 19 in 95% yield. Cleavage of the 1,2-O-isopropylidene group of compound 19 afforded lactol 20, which was converted to corresponding ene-diol 21 as mentioned in scheme-3 with 76% overall yield for two steps. Ene-diol 21 was transformed into the fully protected ene 22 as mentioned in scheme-4 in 88% yield (SCHEME-5).
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             The same prototcol (hydroboration, Collin’s oxidation, PDC oxidation and lactonization) was applied for the synthesis of target chiral lactone 3B starting from compound 22 as mentioned in scheme-4 (SCHEME-6). 


          
           In conclusion, we have successfully envisaged and executed a simple and efficient protocol for the stereoselective synthesis of atorvastatin lactone moiety in two different
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models (3A, 3B) using a chiron approach starting from abundantly available carbohydrate precursor D-glucose by employing simple, novel synthetic strategies like regioselective hydrolysis, olefination and lactonisation.

Chapter-IV: A chiron approach to (1S, 1’R, 5’R, 7’R)-1 and (1S, 2R, 5R, 7S)-2-hydroxy-exo-brevicomins. 
           In 1996, Francke et.al identified (1S, 1’R, 5’R, 7’R   )-1-hydroxy-exo-brevicomin 1 and (1R, 2S, 5S, 7R)-2-hydroxy-exo-brevicomin 2 in the head space volatiles of the male mountain pine beetle, Dendroctonus ponderosae, which plays a major role in their communication systems. Pheromones play a vital role in the pest control management.  Pheromones are a commonly used component of many insect IPM programs. It is the sex pheromones of insects that are of particular interest to agricultural integrated pest management (IPM) practitioners (Figure 1).



                 The retrosynthetic analysis for (1S, 1’R, 5’R, 7’R)-1-hydroxy-exo-brevicomin 1 is based on chiron approach, using D-glucono-δ-lactone 3 as a replenishable starting material. Our retrosynthetic analysis revealed disconnections of the target molecule 1, which led to the trihydroxy-protected alkene 14. We envisioned that completion of the synthesis of 1 relied on the alkylation reaction of primary tosylate 13 which was expected to be derived from diol 10. Synthesis of diol 10 was achieved via the sequence of reactions carried out starting from D-glucono-δ-lactone 3 (SCHEME-1).     
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           D-glucono-δ-lactone 3 was converted to α-hydroxy ester 4 by a well documented procedure. The reduction of α-hydroxy ester 4 with LiAlH4 in dry THF at 0 0C afforded the diol 5 in 96% yield. Treatment of diol 5 with p-TsCl and Et3N in presence of a catalytic dibutyltinoxide in dry DCM to give primary tosylate 6 in 96% yield. Primary tosylate 6 was converted to its corresponding deoxy-alcohol 7 using NaBH4 in dry DMSO with 95% yield. The regioselective monohydrolysis of 5,6-acetonide group of deoxy-alcohol 7 with catalytic p-TSA in methanol at room temperature afforded the triol 8 in 90% yield SCHEME-2). 
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            The triol 8 was treated with NaIO4 in presence of aqueous NaHCO3 in DCM to afford the aldehyde 9 with 95% yield, which was reduced to diol 10 using NaBH4 in dry methanol with 90% yield. The diol 10 was converted to disilyl ether 11 using TBDMSCl, imidazole and catalytic DMAP in dry DCM with 98% yield. Selective liberation of the primary silyl group of disilyl ether 11 was achieved by exposure of 11 to a catalytic p-TSA in methanol at -10 0C for 10 min, which gives primary alcohol 12 in 75% yield (SCHEME-3). 
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           The tosylation of primary hydroxyl group of alcohol 12 was achieved under standard conditions using Et3N, TsCl and catalytic  DMAP in dry DCM to affords primary tosylate 13 in 96% yield. The tosylate 13 was subjected to a Grignard cross-coupling reaction using 3-butenylmagnesiumbromide, cuprous (I) iodide in presence of a small crystal of iodine in dry THF at -20 0C to 17 0C (the final temperature after stirring overnight) to give trihydroxy-protected alkene coupling product 14 in 75% yield. The alkene 14 under Wacker oxidation conditions (PdCl2, CuCl in water and DMF at room temperature under oxygen atmosphere) produced the target molecule (1S, 1’R, 5’R, 7’R)-1-hydroxy-exo-brevicomin 1 in 74% yield (SCHEME-4).    
   


          After, having successfully studied the formation of (1S, 1’R, 5’R, 7’R)-1-hydroxy-exo-brevicomin 1 starting from D-glucono-δ-lactone 3, we then proceeded to synthesize the (1S, 2R, 5R, 7S)-2-hydroxy-exo-brevicomin 2a using the same starting material.
           Our retrosynthetic analysis for (1S, 2R, 5R, 7S)-2-hydroxy-exo-brevicomin 2a suggested that the target compound could be acquired from the isomeric mixture of α, β-unsaturated enones 20, 20a using hydrogenation protocol in acidic media. The enones 20, 20a would be expected to be readily obtained from chiral pool material D-glucono-δ-lactone 3 via epoxide 15 and diol 18 involving simple and efficient transformations (SCHEME-5).
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           The primary tosylate 6, which was derived from D-glucono-δ-lactone 3, was transformed to corresponding epoxide 15 by treating with potassium carbonate in dry methanol with 90% yield. Selective opening of the terminal epoxide 15 with trimethyl aluminium in presence of n-BuLi in dry toluene to afford alcohol 16 in 93% yield. The hydroxyl group of compound 16 was protected as its benzyl ether 17 using sodium hydride (60% w/v dispersion oil), benzyl bromide in anhydrous THF in 92% yield (SCHEME-6).
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           Acidic hydrolysis of the benzylic ether 17 using catalytic p-TSA in methanol provided diol 18 in 90% yield. Oxidative cleavage of the diol 18 with sodium periodate in presence of aqueous NaHCO3   in DCM furnished the aldehyde 19 in 95% yield. The crude aldehyde 19 was subjected to Wittig olefination protocol using (2-oxopropylidene) triphenylphosphorane in dry DCM to yield the isomeric mixture of α, β-unsaturated enones 20, 20a in 75% yield (20:20a = 9:1 by 1H NMR). Hydrogenation of the mixture of enones 20, 20a in presence of a catalytic Pd-C and aqueous HCl in methanol under hydrogen atmosphere to afford the required target compound 2a in 40% yield (SCHEME-7). 


                  In conclusion, we have demonstrated a highly efficient chiron approach for the synthesis of (1S, 1’R, 5’R, 7’R)-1-hydroxy-exo-brevicomin 1 (Natural pheromone) and (1S, 2R, 5R, 7S)-2-hydroxy-exo-brevicomin 2a (synthetic pheromone) starting from D-glucono-δ-lactone involving Grignard cross coupling reaction, Wacker oxidation, selective opening of terminal epoxide and acid catalyzed one pot hydrogenation-internal acetalization as the key steps.   
























